Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

China Pharma Holdings (CPHI) Equity Ratio: 2010-2024

Historic Equity Ratio for China Pharma Holdings (CPHI) over the last 15 years, with Dec 2024 value amounting to 0.52.

  • China Pharma Holdings' Equity Ratio rose 8.51% to 0.53 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.53, marking a year-over-year increase of 8.51%. This contributed to the annual value of 0.52 for FY2024, which is 14.98% up from last year.
  • As of FY2024, China Pharma Holdings' Equity Ratio stood at 0.52, which was up 14.98% from 0.45 recorded in FY2023.
  • China Pharma Holdings' Equity Ratio's 5-year high stood at 0.52 during FY2024, with a 5-year trough of 0.24 in FY2022.
  • In the last 3 years, China Pharma Holdings' Equity Ratio had a median value of 0.45 in 2023 and averaged 0.40.
  • As far as peak fluctuations go, China Pharma Holdings' Equity Ratio dropped by 29.90% in 2021, and later skyrocketed by 87.64% in 2023.
  • Over the past 5 years, China Pharma Holdings' Equity Ratio (Yearly) stood at 0.38 in 2020, then declined by 29.90% to 0.27 in 2021, then dropped by 9.21% to 0.24 in 2022, then soared by 87.64% to 0.45 in 2023, then climbed by 14.98% to 0.52 in 2024.